Clinical Trials Logo

Foot Diseases clinical trials

View clinical trials related to Foot Diseases.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT06261684 Recruiting - Plantar Wart Clinical Trials

Intralesional Acyclovir Versus Cryotherapy in the Treatment of Plantar Warts. A Randomized Controlled Trial.

Start date: October 1, 2023
Phase: Phase 2/Phase 3
Study type: Interventional

The goal of this prospective randomized controlled study is to study the safety and efficacy of intralesional acyclovir compared to cryotherapy in plantar warts. The main questions needed to be answered are: 1. Is Intralesional acyclovir safe for plantar warts? 2. Is Intralesional acyclovir more efficient in treating plantar warts compared to cryotherapy?

NCT ID: NCT06214559 Recruiting - Warts Clinical Trials

Evaluate the Effectiveness and the Safety of a Medical Device in the Treatment of Common Warts and Plantar Warts.

Start date: February 19, 2024
Phase: N/A
Study type: Interventional

The principal aim of this study is to evaluate the efficacy and the safety of the tested product on common and plantar wart after 35 days of treatment. For this study, 33 patients presenting at least one common wart on the fingers, back on the hand or a plantar wart of a size between 0.1 and 0.5cm and present since less than 6 months will be included to reach this objective

NCT ID: NCT06086418 Recruiting - Ankle Injuries Clinical Trials

Perineural Dexamethasone on the Duration of Popliteal Nerve Block for Anesthesia After Pediatric Ankle Surgery

Start date: October 17, 2023
Phase: Phase 4
Study type: Interventional

Effect of Perineural Dexamethasone on the duration of popliteal nerve block for Anesthesia After Pediatric ankle/foot surgery.

NCT ID: NCT05922618 Recruiting - Clinical trials for Complex Regional Pain Syndromes

Pulsed Electromagnetic Fields (PEMFS) in Complex Regional Pain Syndrome Type i (CRPS-I) of the Foot (PeCFoA)

(PeCFoA)
Start date: August 1, 2023
Phase: N/A
Study type: Interventional

The investigators hypothesize that the association of I-ONE® therapy with standard rehabilitation treatment can optimize the clinical and functional recovery of patients with pulsed electromagnetic fields (PEMFs) (I-ONE® therapy) of the foot or ankle.

NCT ID: NCT05520658 Recruiting - Plantar Wart Clinical Trials

Evaluation of the Efficacy of Intralesional Injection of Combined Digoxin and Furosemide Versus 5 - Fluorouracil in Treatment of Plantar Warts

Start date: July 1, 2022
Phase: N/A
Study type: Interventional

Warts are common skin infections caused by human papillomavirus (HPV), which can cause a variety of skin presentations according to its type, site and the immune status .Nongenital warts may be presented as common, plane, plantar, filiform, or mucosal warts .Most people are affected by cutaneous warts, either plantar warts or common warts .prevalence of skin warts is between 3% and 13% and plantar warts are about 30% of skin warts in western world .Majority of cases occur in adolescent and young adults

NCT ID: NCT05429151 Recruiting - Clinical trials for Acyclovir and Candida Antigen in Treatment of Plantar Wart

Intralesional Injection of Acyclovir Versus Candida Antigen in Treatment of Plantar Warts

Start date: June 13, 2022
Phase: Phase 4
Study type: Interventional

This study aims to evaluate the efficacy of intralesional injection of acyclovir versus candida antigen in plantar wart patients will be randomly divided into 2 groups,At least 20 patients will be enrolled in each group. Group 1: will be treated with intralesional injection of acyclovir 250 mg acyclovir vial diluted with 3.5 ml saline to get approximately 70 mg/ml solution. The base of each wart was injected with 0.1 ml of intralesional acyclovir (70 mg/ml) every 2 weeks until the resolution of warts or for a maximum of 5 sessions Group 2: will be treated by intralesional Candida antigen injection (candida antigen ) at a dose of 0.2 mL. injected into the largest wart every 2 weeks until complete clearance of warts or for a maximum of 5 treatment sessions. 3.Patient evaluation: Assessment of treatment efficacy and side effects will be carried out by clinical examination and comparative photographic evaluation and dermoscopy

NCT ID: NCT04814446 Recruiting - Clinical trials for Palmar or Plantar Warts

Nonavalent HPV Vaccine in the Treatment of Difficult-to-treat Palmo-plantar Warts

VAC-WARTS
Start date: June 29, 2022
Phase: Phase 3
Study type: Interventional

Cutaneous viral warts are very common and are caused by the human papilloma virus (HPV). Most people experience warts in one form or another at some point in their lives. Cutaneous warts are related to different types of HPV. For the palms and soles, HPV 2 has been the most frequently found but HPV 1, 4, 27, and 57 have also been described. Our hypothesis is that vaccination by nonavalent vaccine against HPV could lead to a complete resolution of difficult-to-treat palmo-plantar warts patients of more than 15 years and 3 months of age.

NCT ID: NCT04423900 Recruiting - Plantar Fascitis Clinical Trials

Smart Phone-Based Application for Evaluation and Rehabilitation of HindFoot Pain

Start date: September 1, 2020
Phase: N/A
Study type: Interventional

This randomized controlled study aims to evaluate the status of the individuals with hindfoot pain and to recommend preventive precautions and appropriate exercise programs with Smart Phone-Based Applications. Additionally, to compare the results of patients who attended through mobile applications (Achilles Tendinopathy and Plantar Fasciitis) with the results of patients included in the hands-on program.

NCT ID: NCT02151630 Recruiting - Plantar Wart Clinical Trials

Pyruvic Acid Versus Salicylic Acid Preparation in Treatment of Plantar Warts

Start date: May 2014
Phase: Phase 2/Phase 3
Study type: Interventional

Plantar warts can be bothersome and painful requiring treatment. The investigators will compare the efficacy of pyruvic acid and salicylic acid in treating multiple plantar warts. Patients with multiple plantar warts will be randomized to receive either pyruvic acid 70% or compound salicylic acid solution (salicylic acid 16.7%, lactic acid 16.7%, and collodion 100%) applying topically twice a day for 4 weeks. Patients will be visited every 2 weeks for one month after starting treatment and then every one month for up to 3 months. The number and size of warts will be evaluated.